Elisabetta Faenza


Elisabetta’s journey was prompted by a childhood diagnosis of a rare, deadly genetic condition, which led her on a quest to understand how our bodies, medicines, nutrition and the environment interact to switch damaging genes on and off. Before co-founding LeafCann Group, an Australian licenced Medicinal Cannabis company now also operating in the UK, Elisabetta’s work as a clinical hypnotherapist, corporate speaker and mentor assisted thousands of individuals to change unwanted behaviours, recover from trauma and achieve personal and career goals. Prior to LeafCann Elisabetta was founding CEO of the Mulloon Institute, a regenerative farming research institute, and was a senior executive in the Nutraceutical sector. In LeafCann, Elisabetta has brought together a talented team of experts from biomedicine, clinical research, quality assurance, education and training, controlled medicinal cannabis cultivation, extraction, policy, project management, facility design, regulatory affairs and IP management. Elisabetta manages a global team on three continents, all working to produce the highest quality Medicinal Cannabis products under GMP.

Comments are closed.